P. Grandjean et al., PLACEBO-RESPONSE IN ENVIRONMENTAL DISEASE - CHELATION-THERAPY OF PATIENTS WITH SYMPTOMS ATTRIBUTED TO AMALGAM FILLINGS, Journal of occupational and environmental medicine, 39(8), 1997, pp. 707-714
Treatment of patients who attribute their environmental illness to mer
cury from amalgam fillings is largely experimental. On the Symptom Che
ck List, overall distress, and somatization, obsessive-compulsive, dep
ression, and anxiety symptom dimensions, were increased in 50 consecut
ive patients examined and Eysenck Personality Questionnaire sco res su
ggested less extroversion and increased degree of emotional lability.
Succimer (meso-2, 3-dimercaptosuccinic acid) was given at a daily dose
of 30 mg/kg for five days in a double-blind, randomized placebo-contr
olled trial, Urinary excretion of mercury and lead was considerably in
creased in the patients who received the chelator: Immediately after t
he treatment and 5 to 6 weeks later, most distress dimensions had impr
oved considerably, but there was no difference between the succimer an
d placebo groups. These findings suggest that some patients with envir
onmental illness may substantially benefit from placebo.